Țară: Statele Unite ale Americii
Limbă: engleză
Sursă: NLM (National Library of Medicine)
FOSPHENYTOIN SODIUM (UNII: 7VLR55452Z) (PHENYTOIN - UNII:6158TKW0C5)
West-Ward Pharmaceuticals Corp
FOSPHENYTOIN SODIUM
PHENYTOIN SODIUM 50 mg in 1 mL
INTRAMUSCULAR
PRESCRIPTION DRUG
Fosphenytoin Sodium Injection, USP is indicated for the treatment of generalized tonic-clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery. Fosphenytoin Sodium Injection, USP can also be substituted, short-term, for oral phenytoin. Fosphenytoin Sodium Injection, USP should be used only when oral phenytoin administration is not possible [see Dosage and Administration (2.4) and Warnings and Precautions (5.2) ]. Fosphenytoin Sodium Injection is contraindicated in patients with: - A history of hypersensitivity to Fosphenytoin Sodium Injection or its inactive ingredients, or to phenytoin or other hydantoins [see Warnings and Precautions (5.6)] . - Sinus bradycardia, sino-atrial block, second and third degree A-V block, or Adams-Stokes syndrome because of the effect of parenteral phenytoin or Fosphenytoin Sodium Injection on ventricular automaticity. - A history of prior acute hepatotoxicity attributable to Fosphenytoin Sodium Injection or phenytoin [see Warnings and Pr
Fosphenytoin Sodium Injection, USP Injection is a clear, colorless to pale yellow sterile solution supplied as follows: mg phenytoin sodium equivalents (PE) per vial Volume per vial (mL) Package Configuration NDC 500 mg PE/10 mL vial 10 mL per vial Package contains 10 vials of NDC 0143-9782-01 NDC 0143-9782-10 100 mg PE/2 mL vial 2 mL per vial Package contains 25 vials of NDC 0143-9788-01 NDC 0143-9788-25 Both sizes of vials contain Tromethamine, USP (TRIS), Hydrochloric Acid, NF, or Sodium Hydroxide, NF, and Water for Injection, USP. Fosphenytoin Sodium Injection, USP should always be prescribed in phenytoin sodium equivalents (PE) [see Dosage and Administration (2.1) and Warnings and Precautions (5.1)] . 1.5 mg of fosphenytoin sodium is equivalent to 1 mg phenytoin sodium, and is referred to as 1 mg PE. The amount and concentration of fosphenytoin is always expressed in terms of mg of phenytoin sodium equivalents (PE). Fosphenytoin's weight is expressed as phenytoin sodium equivalents to avoid the need to perform molecular weight-based adjustments when substituting fosphenytoin for phenytoin or vice versa. Store under refrigeration at 2°C to 8°C (36°F to 46°F). The product should not be stored at room temperature for more than 48 hours. Vials that develop particulate matter should not be used. Injection vials are single-dose only. After opening, any unused product should be discarded.
Abbreviated New Drug Application
FOSPHENYTOIN SODIUM- FOSPHENYTOIN SODIUM INJECTION, SOLUTION WEST-WARD PHARMACEUTICALS CORP ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE FOSPHENYTOIN SODIUM INJECTION, USP SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR FOSPHENYTOIN SODIUM INJECTION, USP. FOSPHENYTOIN SODIUM INJECTION, USP FOR INTRAVENOUS OR INTRAMUSCULAR USE INITIAL U.S. APPROVAL: 1996 WARNING: CARDIOVASCULAR RISK ASSOCIATED WITH RAPID INFUSION RATES _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._ THE RATE OF INTRAVENOUS FOSPHENYTOIN SODIUM INJECTION ADMINISTRATION SHOULD NOT EXCEED 150 MG PHENYTOIN SODIUM EQUIVALENTS (PE) PER MINUTE IN ADULTS AND 2 MG PE/KG/MIN (OR 150 MG PE/MIN, WHICHEVER IS SLOWER) IN PEDIATRIC PATIENTS BECAUSE OF THE RISK OF SEVERE HYPOTENSION AND CARDIAC ARRHYTHM IAS. CAREFUL CARDIAC MONITORING IS NEEDED DURING AND AFTER ADMINISTERING INTRAVENOUS FOSPHENYTOIN SODIUM INJECTION. REDUCTION IN RATE OF ADMINISTRATION OR DISCONTINUATION OF DOSING MAY BE NEEDED (2.3, 2.4, 5.2). RECENT MAJOR CHANGES Dosage and Administration (2.3, 2.4) 3/2017 Contraindications (4) 3/2017 Warnings and Precautions (5.2) 3/2017 Warnings and Precautions (5.14) 10/2017 Warnings and Precautions (5.17) 3/2017 INDICATIONS AND USAGE Fosphenytoin Sodium Injection, USP is indicated for the treatment of generalized tonic-clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery. Fosphenytoin Sodium Injection, USP can also be substituted, as short-term use, for oral phenytoin. Fosphenytoin Sodium Injection, USP should be used only when oral phenytoin administration is not possible. (1) DOSAGE AND ADMINISTRATION THE DOSE, CONCENTRATION, AND INFUSION RATE OF FOSPHENYTOIN SODIUM INJECTION SHOULD ALWAYS BE EXPRESSED AS PHENYTOIN SODIUM EQUIVALENTS (PE) (2.1) FOR STATUS EPILEPTICUS: Adult loading dose is 15 to 20 mg PE/kg at a rate of 100 to 150 mg PE/min (2.3) Pediatric loading dose is 15 to 20 mg PE/kg at a rate of 2 mg PE/kg/min Citiți documentul complet